Gilead Sciences
GILD
#129
Rank
NZ$260.36 B
Marketcap
NZ$209.83
Share price
-1.14%
Change (1 day)
35.99%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): NZ$17.01 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$29.08 Billion. In 2024 the company made an earning of NZ$1.19 Billion a decrease over its 2023 earnings that were of NZ$11.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$17.01 B1324.94%
2024 NZ$1.19 B-89.94%
2023 NZ$11.87 B17.97%
2022 NZ$10.06 B-29.77%
2021 NZ$14.32 B395.99%
2020 NZ$2.88 B-67.66%
2019 NZ$8.93 B-33.84%
2018 NZ$13.50 B-42.35%
2017 NZ$23.41 B-20.87%
2016 NZ$29.59 B-21.06%
2015 NZ$37.49 B45.8%
2014 NZ$25.71 B253.01%
2013 NZ$7.28 B16.51%
2012 NZ$6.25 B-1.07%
2011 NZ$6.31 B-6.71%
2010 NZ$6.77 B11.75%
2009 NZ$6.06 B29.5%
2008 NZ$4.68 B19.11%
2007 NZ$3.92 B-455.74%
2006 -NZ$1.11 Billion-154.93%
2005 NZ$2.01 B76.99%
2004 NZ$1.13 B-266.16%
2003 -NZ$0.69 Billion-638.24%
2002 NZ$0.12 B31.5%
2001 NZ$96.61 M-242.15%
2000 -NZ$67.98 Million-40.2%
1999 -NZ$0.12 Billion31.85%
1998 -NZ$86.21 Million8.73%
1997 -NZ$79.28 Million27.22%
1996 -NZ$62.32 Million
1994 -NZ$59.38 Million26.57%
1993 -NZ$46.92 Million46.49%
1992 -NZ$32.03 Million362.5%
1991 -NZ$6.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$14.27 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$7.72 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.87 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.72 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.29 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.51 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.07 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.95 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.96 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA